Serina Therapeutics Inc.

AI Score

XX

Unlock

5.28
0.53 (11.16%)
At close: Mar 28, 2025, 3:50 PM
5.30
0.38%
After-hours: Mar 28, 2025, 05:19 PM EDT

Serina Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 142K 500K 3.04M 54K 1.73M 1.4M 1.4M 1.67M
Cost of Revenue 171K 145K 150K 1.28M 998.5K 841K 685K 911K
Gross Profit -29K 355K 2.89M -1.23M 729.5K 555K 719K 755K
Operating Income -9.96M -2.27M -1.63M -10.41M -12.56M -10.45M -8.42M -12.74M
Interest Income n/a 1.76K 10.86K n/a 29K 116K n/a n/a
Pretax Income -14.81M -2.68M -1.26M -10.4M -12.24M -7.73M -6.64M -17.36M
Net Income -14.8M -2.68M -1.26M -10.87M -12.15M -7.5M -6.58M -15.49M
Selling & General & Admin 9.33M 1.29M 1.3M 5.6M 7.94M 5.65M 3.87M 5.62M
Research & Development 603K 1.57M 3.8M 3.58M 5.35M 5.35M 5.27M 7.87M
Other Expenses n/a -265.92K n/a n/a n/a n/a n/a n/a
Operating Expenses 9.93M 2.77M 4.67M 9.18M 13.29M 11M 9.14M 13.49M
Interest Expense 558K 15.88K 3.09K 404K n/a n/a 12K 25K
Selling & Marketing Expenses 5.43M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 10.1M 2.77M 4.67M 10.46M 14.29M 11.84M 9.82M 14.4M
Income Tax -8K -250.04K 3.09K 466K 148K -229K -57K -1.86M
Shares Outstanding (Basic) 8.41M 1.08M 1.08M 1.07M 1.06M 992.72K 1.02M 1.02M
Shares Outstanding (Diluted) 8.41M 1.08M 1.08M 1.07M 1.06M 992.72K 1.02M 1.02M
EPS (Basic) -1.76 -2.49 -1.17 -10.14 -11.47 -7.56 -6.46 -15.21
EPS (Diluted) -1.76 -2.49 -1.17 -10.14 -11.47 -7.56 -6.46 -15.21
EBITDA -9.78M -2.6M -1.59M -8.74M -11.61M -7.2M -7.74M -11.89M
Depreciation & Amortization 131K 132K 131K 1.25M 951K 535K 682K 845K